I think FitBit is a great company with great products. However, i think the market itself is at an inflection point and will experience some pain the next few months which will bring down some of these high valuation stocks. If this was 2 months ago, we would of erased a lot, maybe not all of todays losses but definitely made new highs within a week or two.
Never hold a stock into earnings. Those big bounces you see in amzn, nflx, and goog are an exception. You can always buy after earnings and miss some upside opposed to getting smacked. You just necer know how the street will interpret.
I cant find any data saying this procedure provides immediate refief and a strong urine stream.
NYMX apparantly shrinks the prostate and provides relief for over 3 years and the injection is painless plus no sexual side effects. Both should be very viable solutions for those with BPH.
The only side effect for flomax are nasal congenstion and retrograde. Uroxatral has no retrograde. What other side effects are associated with those two drugs?
The injection actually shrinks the prostate, goves very long term symptom relief and no side effects. If this is approved it will be great for shaeholders but more importantly, great for guys who suffer from bph symptoms.
I actually heard botox is being used for bph, anyone hear of that?
Although goro amd amba go higher, i believe both will pull back about 10%. Based on all the reports about robust sales and a so,id outlook , FIT will be $75 very shortly based on momentum.
FIT is the better short term trade . GPRO is going to 100 in my view, im serious, as will FIT. I think FIT will hit 75 quickly especially if earnings are good. Everyone is looking fot the next momentum stock, i think FIT is the one.